In addition to cytokine-driven activation of pStat3 signaling, human gastric cancers exhibit alterations in several other signaling pathways, including receptor tyrosine kinase/MAPK and PI3K/Akt/mTOR pathways (reviewed in [27]). The gene discussed is AKT1; the disease is gastric cancer.